A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease

NCT01316601 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gerhard Rogler

Collaborators